Analysts have been eager to weigh in on the Healthcare sector with new ratings on Minerva Neurosciences (NERV – Research Report), Agilon Health (AGL – Research Report) and Axsome Therapeutics (AXSM – Research Report).
Minerva Neurosciences (NERV)
BTIG analyst Thomas Shrader maintained a Buy rating on Minerva Neurosciences yesterday and set a price target of $6.00. The company’s shares closed last Monday at $4.59, close to its 52-week low of $2.51.
According to TipRanks.com, Shrader is a 1-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Minerva Neurosciences with a $13.50 average price target, which is a 310.3% upside from current levels. In a report issued on August 10, JMP Securities also reiterated a Buy rating on the stock with a $21.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Agilon Health (AGL)
In a report released yesterday, David Larsen from BTIG maintained a Hold rating on Agilon Health. The company’s shares closed last Monday at $21.20.
According to TipRanks.com, Larsen has 0 stars on 0-5 stars ranking scale with an average return of
Currently, the analyst consensus on Agilon Health is a Strong Buy with an average price target of $31.20.
Axsome Therapeutics (AXSM)
In a report issued on August 19, Robert Hazlett from BTIG reiterated a Buy rating on Axsome Therapeutics, with a price target of $62.00. The company’s shares closed last Monday at $64.46.
According to TipRanks.com, Hazlett is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Axsome Therapeutics with a $71.89 average price target, implying a 20.8% upside from current levels. In a report issued on August 10, Cantor Fitzgerald also maintained a Buy rating on the stock with a $54.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on NERV:
- Analysts Offer Insights on Technology Companies: Splunk (SPLK), fuboTV (FUBO) and Bill.com Holdings (BILL)
- Analysts Offer Insights on Materials Companies: O-I Glass (OI) and New Hope Corporation Limited (OtherNHPEF)
- Analysts Offer Insights on Financial Companies: Equity Residential (EQR) and Rithm Capital (RITM)
- BTIG Keeps Their Buy Rating on Lucid Diagnostics (LUCD)
- BTIG Reaffirms Their Hold Rating on T2 Biosystems (TTOO)
